Eti Mitrany

Eti Mitrany

Director/Board Member at BRAINSWAY LTD.

Net worth: 405 959 $ as of 31/05/2026

56 year
Health Technology
Consumer Services
Commercial Services

Profile

Ms. Eti Mitrany is an Independent Director at Brainsway Ltd., a Chairman at Derma Gene Ltd. and a Chief Executive Officer at Israeli Investors Forum.
She is on the Board of Directors at Trioxnano Ltd. and Brainsway Ltd. Ms. Mitrany was previously employed as a Chief Financial Officer & Head-Corporate Strategy by CytoReason Ltd., a Senior Vice President-Head of Economic by Teva Pharmaceutical Industries Ltd., and a Global Chief Financial Officer by Copaxone.
She received her undergraduate degree from Tel-Aviv University and an MBA from Tel-Aviv University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/05/2026 12,500 ( 0.03% ) 207 334 $ 31/05/2026
26/05/2026 12,500 ( 0.06% ) 198 625 $ 31/05/2026

Eti Mitrany active positions

CompaniesPositionStart
BRAINSWAY LTD. Director/Board Member 05/06/2016
Trioxnano Ltd.
Director/Board Member 01/01/2023

Former positions of Eti Mitrany

CompaniesPositionEnd
Director of Finance/CFO 01/12/2022
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01/01/2020
Copaxone
Director of Finance/CFO -
See the detail of Eti Mitrany's experience

Training of Eti Mitrany

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Health Technology

Copaxone

Trioxnano Ltd.

Commercial Services

Technology Services